灵洋品牌怎么样 申请店铺

我要投票 灵洋在医疗器械行业中的票数:643 更新时间:2026-01-29
灵洋是哪个国家的品牌?「灵洋」是 浙江灵洋医疗器械有限公司 旗下著名品牌。该品牌发源于浙江省台州市,由创始人胡军飞在2000-12-25期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力灵洋品牌出海!将品牌入驻外推网,定制灵洋品牌推广信息,可以显著提高灵洋产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

灵洋怎么样

浙江灵洋医疗器械有限公司,坐落在临海市的西部开发区。公司的前身是成立于1987年的临海市医疗器械厂,创办之初即定位于一次性医疗器械的专业制造。

公司总占地面积80亩,总建筑面积5.5万平方米,其中10万级洁净厂房1.6万平方米。现有员工760人,管理人员91人,研发人员39人。

2012年以来,公司结合“医疗器械质量管理规范”的要求,在生产自动化方面加大投入,投资2000多万元,对现有洁净车间进行改造,引进各零部件自动组装机、包装线等国内外全自动生产线,以自动化设备替代手工操作,大大提高生产效率;同时具备全套的检测仪器,为企业的发展提供质量保障。

历年来,公司本着“锐意进取,开拓创新,永无止境”的企业精神,围绕“分秒求创新 点滴显真情”的价值观,专注于科技型、人性化产品的创新活动。通过ISO9001质量体系,ISO14001环境体系和OHSAS18001体系认证,针对每个产品每道工序,公司制定产品生产工艺流程与工艺指导文件,共建立100多个控制文件,生产过程严格执行工艺文件规定,每道工艺经过验证评价后使用。按各产品质量要求制定进货检验、过程控制和出厂检验等规范,并设立90多个生产过程质量控制点。

经过多年的创新与发展,现已成为行业内主导生产一次性输液器类、注射器类和氧疗护理类三大系列产品的企业。先后申请获得16项发明专利和实用新型专利。自主开发组合钢针型输液器、一次性使用低阻力注射器、一次性使用精密过滤输液器、一次性使用组合吸痰管等专利产品。低阻力注射器、组合吸痰管、离子膜精密过滤输液器,不断的技术创新和产品开发成就企业一个又一个亮点,为企业的发展奠定基础。

优质的产品,良好的企业形象,促进公司不断持续地发展,现在灵洋公司集研发、生产、销售于一体,在各地设有几十个分公司和办事处,销售网络覆盖全国。

“灵洋”是一支具有高度凝聚力、创新力和战斗力的团队,正以“海纳百川”的气魄热忱的欢迎四方人才的加盟;以“同甘苦、共荣辱”的协作精神推动灵洋公司向国际化企业集团昂首奋进。


Zhejiang Lingyang Medical Equipment Co., Ltd. is located in the Western Development Zone of Linhai City. The predecessor of the company is Linhai medical device factory, which was founded in 1987. At the beginning of its establishment, it was located in the professional manufacturing of disposable medical devices. The company covers an area of 80 mu, with a total construction area of 55000 square meters, including 16000 square meters of 100000 level clean workshop. At present, there are 760 employees, 91 management personnel and 39 R & D personnel. Since 2012, the company has increased investment in production automation in accordance with the requirements of "medical device quality management standard", invested more than 20 million yuan, renovated the existing clean workshop, introduced automatic assembly machines, packaging lines and other fully automatic production lines at home and abroad, replaced manual operation with automatic equipment, greatly improving production efficiency; at the same time, it has a full set of detectors To provide quality assurance for the development of enterprises. Over the years, based on the enterprise spirit of "forge ahead, develop and innovate, never-ending", focusing on the value of "seeking innovation every minute to show the truth", the company has focused on the innovation activities of technology-based and humanized products. Through ISO9001 quality system, ISO14001 environmental system and OHSAS18001 system certification, the company has developed product production process and process guidance documents for each process of each product, and established more than 100 control documents in total. The production process strictly complies with the requirements of process documents, and each process is used after verification and evaluation. Formulate incoming inspection, process control and delivery inspection specifications according to product quality requirements, and set up more than 90 production process quality control points. After years of innovation and development, it has become a leading manufacturer of three series of products in the industry: disposable infusion sets, syringes and oxygen therapy nursing. It has applied for 16 invention patents and utility model patents. Independent development of combination of steel needle infusion set, disposable low resistance syringe, disposable precision filter infusion set, disposable combination suction tube and other patented products. Low resistance syringe, combined suction tube, ion-exchange membrane precision filtration infusion set, continuous technological innovation and product development have made the enterprise one by one bright spot, laying the foundation for the development of the enterprise. High quality products and good corporate image promote the continuous development of the company. Now Lingyang company integrates R & D, production and sales. It has dozens of branches and offices all over the country, with sales network covering the whole country. "Lingyang" is a team with high cohesion, innovation and combat effectiveness. With the spirit of "embracing all rivers and seas", we warmly welcome the talents from all over the world to join us. With the spirit of "sharing weal and woe, sharing honor and Disgrace", we are pushing Lingyang company forward to an international enterprise group.

本文链接: https://brand.waitui.com/c74a5fb5e.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

万辰集团:2025年净利同比预增222.38%-266.94%

36氪获悉,万辰集团发布2025年业绩预告。报告显示,预计2025年归属于上市公司股东的净利润为12.30亿元-14.00亿元,比上年同期(重组后)增长222.38%-266.94%。业绩变动主要系量贩零食零售业务规模扩张、销售及利润率提升,叠加食用菌业务下半年企稳回暖、价格与毛利率上升所致。

2小时前

阿斯利康计划到2030年在中国投资150亿美元

1月29日,阿斯利康宣布,将在2030年前向中国投资150亿美元,用于扩大药品研发和生产。(界面)

2小时前

嬴彻科技再登“木头姐”年度报告Big Ideas 2026,智能辅助驾驶系统商业运营里程超5亿公里

近日,嬴彻科技再度入选知名投资人“木头姐”Cathie Wood旗下ARK Invest年度报告《Big Ideas 2026》。报告显示,嬴彻科技商业运营里程位居全球前列。截至目前,其智能辅助驾驶系统商业运营里程已超5亿公里,中国高速覆盖率达97%。嬴彻海量智驾数据的指数级增长,将不断扩大其数据资产的规模和质量优势,加速算法迭代,强化技术领先优势,在商用车自动驾驶领域形成稀缺性壁垒。

2小时前

浙江荣泰电工器材股份有限公司向港交所提交上市申请书

36氪获悉,据港交所文件,浙江荣泰电工器材股份有限公司向港交所提交上市申请书,独家保荐人为中信证券。

2小时前

国中水务:可能被实施退市风险警示

36氪获悉,国中水务公告,预计2025年年度实现利润总额-11000万元到-8800万元;归属于母公司所有者的净利润-13000万元到-10400万元,将出现亏损;扣除非经常性损益后的净利润为900万元到1080万元;营业收入21000万元到25200万元,扣除与主营业务无关的业务收入和不具备商业实质的收入后的营业收入为19000万元到22800万元,低于3亿元。将触及《上海证券交易所股票上市规则》第5.1.1条规定的对公司股票实施退市风险警示的情形,公司股票在2025年年度报告披露后可能被实施退市风险警示。

2小时前

本页详细列出关于灵洋的品牌信息,含品牌所属公司介绍,灵洋所处行业的品牌地位及优势。
咨询